Maravai LifeSciences Holdings, Inc.
MRVI
$3.08
-$0.21-6.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -35.68M | -25.56M | -39.59M | -29.95M | -25.91M |
| Total Depreciation and Amortization | 14.73M | 15.44M | 15.39M | 14.91M | 14.53M |
| Total Amortization of Deferred Charges | 403.00K | 399.00K | 391.00K | 461.00K | 658.00K |
| Total Other Non-Cash Items | 17.21M | -10.25M | 12.41M | -306.00K | 6.53M |
| Change in Net Operating Assets | -19.43M | 4.82M | 1.14M | 5.49M | -10.44M |
| Cash from Operations | -22.77M | -15.15M | -10.27M | -9.39M | -14.64M |
| Capital Expenditure | -2.11M | -2.93M | -2.87M | -5.24M | -5.85M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | -362.00K | -18.63M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 734.00K | 918.00K |
| Cash from Investing | -2.11M | -2.93M | -3.24M | -23.13M | -4.93M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -790.00K | -1.56M | -1.55M | -1.54M | -229.86M |
| Issuance of Common Stock | 4.61M | 111.00K | 13.00K | -- | 1.48M |
| Repurchase of Common Stock | -- | -- | -- | -4.73M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.63M | -6.80M | 0.00 | 1.38M | -7.81M |
| Cash from Financing | -1.82M | -8.25M | -1.53M | -4.90M | -236.19M |
| Foreign Exchange rate Adjustments | 14.00K | -8.00K | -111.00K | 73.00K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -26.68M | -26.33M | -15.15M | -37.35M | -255.76M |